Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

Why Is Invo Bioscience (INVO) Stock Up 2,000% Today?

By William White, InvestorPlace Writer
Invo Bioscience (INVO) stock appears to be rocketing higher on Friday but it's actually undergoing a reverse stock split.

7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes

By Joel Baglole, InvestorPlace Contributor
Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.

Why Is National Vision (EYE) Stock Down 12% Today?

By William White, InvestorPlace Writer
National Vision (EYE) stock is dropping on Thursday as a deal it has with Walmart (WMT) is going to come to an end in 2024.

Why Is Lipocine (LPCN) Stock Up 32% Today?

By William White, InvestorPlace Writer
Lipocine (LPCN) stock is rising higher on Thursday after the company released positive results from a Phase 2 clinical trial.

3 Biotech Stocks You Better Be Buying on Each and Every Dip

By Tyrik Torres, InvestorPlace Contributor
Biotech companies can bring about life-changing innovations. We've created a list to help you find the best biotech stocks out there.

3 Risky Stocks to Avoid at All Costs in 2023

By Omor Ibne Ehsan
These are the top stocks to avoid before the stock market rally starts to lose momentum and plateau this year.

If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.

Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts

By William White, InvestorPlace Writer
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.

Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?

By William White, InvestorPlace Writer
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.

Why Is Humanigen (HGEN) Stock Down 72% Today?

By William White, InvestorPlace Writer
Humanigen (HGEN) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements.

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023

By Marie Brodbeck, InvestorPlace Contributor
These three undervalued biotech stocks could have plenty of room to run if their efforts to push out promising pipeline drugs are successful.

Why Is PaxMedica (PXMD) Stock Up Today?

By Josh Enomoto, InvestorPlace Contributor
Although PaxMedica delivered encouraging top-line results for a Phase 3 study, PXMD stock remains a risky investment.

3 Under-the-Radar Growth Stocks With Triple-Digit Upside Potential

By Omor Ibne Ehsan
These under-the-radar growth stocks are in position to deliver triple-digit returns from their current price point.

Why Is Kodiak Sciences (KOD) Stock Down 58% Today?

By William White, InvestorPlace Writer
Kodiak Sciences (KOD) stock is falling hard on Monday after the company released results from a series of Phase 3 clinical trials.

The 3 Best Value AI Stocks to Buy Right Now

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
These new value AI stocks to buy in July have massive upside potential. But they won't stay undervalued for long.

The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023

By Charles Munyi, InvestorPlace Contributor
Trading below a 15 forward price-to-earnings, these undervalued pharma stocks offer opportunities in an overbought market.

3 Low-Risk Cannabis Stocks to Buy for Smoking-Hot Growth

By Yiannis Zourmpanos, InvestorPlace Contributor
The trends in the industry may benefit IIPR, Cronos Group, and WM Technology over the long term due to the progress in their business operations.

Why Is Kiora Pharmaceuticals (KPRX) Stock Down 7% Today?

By William White, InvestorPlace Writer
Kiora Pharmaceuticals (KPRX) stock is dropping on Friday after the clinical-stage pharmaceutical company received a delisting notice.

3 of the Best Dividend Stocks to Buy for Passive Income Growth

By Chris MacDonald, InvestorPlace Contributor
For investors looking to create a meaningful stream of passive income in retirement, these dividends stocks are great options.
Load More Articles